GLUCOSE-SOLOPHARM™ POLYFLAC DOMUS infusion solution 5% (400ml), vial 1pc

GLUCOSE-SOLOPHARM™ 5% Solution 400ml Buy Online

Glucose-Solopharm Polyflac Domus Infusion Solution 5%

Maintaining optimal glucose levels is crucial for bodily functions. Glucose-Solopharm Polyflac Domus 5% infusion solution provides a readily available source of dextrose, essential for energy production and various metabolic processes. This readily-available intravenous solution offers a convenient method for administering glucose when oral intake is insufficient or impossible. Its isotonic nature allows for efficient fluid replenishment.

What is Glucose-Solopharm Polyflac Domus?

Glucose-Solopharm Polyflac Domus is a sterile, isotonic intravenous infusion solution containing 5% dextrose (glucose monohydrate). This means it’s designed to be administered directly into a vein to provide the body with a readily available source of energy and fluids. The solution is packaged in a convenient, single-use 400ml Polyflac Domus vial, ensuring ease of administration and sterility. It’s primarily used for fluid replacement and as a source of carbohydrates, particularly when oral intake is compromised or insufficient.

The primary active ingredient, dextrose, is a simple sugar that the body quickly metabolizes to produce energy. This makes Glucose-Solopharm Polyflac Domus particularly useful in situations where a rapid energy boost is needed, such as during periods of illness or after surgery. The inclusion of a small amount of sodium chloride aids in maintaining proper electrolyte balance during intravenous fluid administration. It is important to note that while this solution provides essential fluids and carbohydrates, it does not contain all the nutrients required for complete nutrition and should be used under medical supervision.

Its isotonic nature is crucial, preventing the disruption of fluid balance within the body. This is in contrast to hypertonic solutions that may draw fluid from cells into the bloodstream and hypotonic solutions that may cause fluid to shift from the bloodstream into cells. This balanced composition minimizes the risk of adverse reactions associated with fluid imbalances. Therefore, the solution is suitable for a range of clinical applications where fluid and glucose replenishment are necessary. Always adhere to the dosage and administration guidelines provided by healthcare professionals to ensure safe and effective use.

Composition and Properties

Glucose-Solopharm Polyflac Domus 5% infusion solution boasts a straightforward yet effective composition. Its core component is dextrose monohydrate, a readily metabolizable form of glucose, present at a concentration of 50g per liter. This ensures a reliable and efficient energy source for the body. A small amount of sodium chloride (0.26g per liter) is also included to help maintain proper electrolyte balance during fluid administration. The solution is prepared using water for injections, adhering to stringent pharmaceutical standards for purity and sterility.

The solution’s isotonic nature is a key property. This means its osmotic pressure is similar to that of blood plasma, preventing fluid shifts that could harm cells. This isotonic balance is crucial for minimizing the risk of adverse effects associated with intravenous fluid administration. The solution is clear, colorless, and free from visible particulate matter, ensuring its suitability for intravenous use. Its sterile packaging in a 400ml Polyflac Domus vial further contributes to maintaining its purity and preventing contamination.

The pH of the solution is carefully controlled to ensure compatibility with the body’s physiological environment. The solution’s properties make it suitable for various clinical needs, including fluid replacement and carbohydrate supplementation. The ease of administration and the rapid metabolic utilization of dextrose contribute to its widespread use in medical settings. Precise details on the specific composition and properties can be obtained from the product’s official package insert or the manufacturer’s specifications. Always consult a healthcare professional for appropriate usage and dosage.

Mechanism of Action

Glucose-Solopharm Polyflac Domus’s mechanism of action centers on the rapid metabolism of its primary component, dextrose. Once administered intravenously, dextrose enters the bloodstream and is readily transported to cells throughout the body. Within these cells, dextrose undergoes phosphorylation, transforming into glucose-6-phosphate, a crucial intermediate in cellular metabolism. This process initiates a cascade of reactions leading to energy production through glycolysis and the Krebs cycle.

This energy production is vital for numerous cellular processes, providing fuel for various bodily functions. Simultaneously, the intravenous administration of the solution directly replenishes fluid volume, addressing dehydration or fluid deficits. The added sodium chloride contributes to maintaining proper electrolyte balance, which is essential for optimal cellular function and overall physiological homeostasis. The isotonic nature of the solution ensures efficient fluid distribution without causing significant osmotic shifts.

The speed at which dextrose is metabolized and utilized for energy is a key advantage of this solution. This rapid energy provision is particularly beneficial in situations where the body requires immediate energy support. The simultaneous fluid replenishment contributes to overall hydration and circulatory support. Consequently, Glucose-Solopharm Polyflac Domus offers a combined therapeutic effect, addressing both energy needs and fluid balance simultaneously, making it a versatile solution in various clinical contexts. The precise metabolic pathways involved are well-established in the field of biochemistry, underlying the solution’s predictable and reliable effects.

Administration and Dosage

Glucose-Solopharm Polyflac Domus 5% infusion solution is administered intravenously, meaning it’s given directly into a vein. The specific dosage and infusion rate are determined by a healthcare professional based on individual patient needs and medical condition. Factors such as the patient’s age, weight, overall health, and the severity of fluid or glucose deficit are considered when determining the appropriate dose. Self-administration is strongly discouraged; always follow a healthcare provider’s instructions.

For adult patients, the maximum infusion rate for a 5% solution is generally recommended to not exceed 7 ml/minute (or 150 drops per minute), translating to a maximum of 400ml per hour. The maximum daily dosage for adults typically does not exceed 2 liters. These parameters are guidelines, and the actual infusion rate and total volume administered will vary depending on the individual patient’s circumstances and response to treatment. Close monitoring of the patient’s fluid balance and blood glucose levels is essential during and after infusion.

Infusion of the solution should be conducted using appropriate sterile techniques to prevent infection. The solution should be visually inspected before administration for any signs of discoloration, cloudiness, or particulate matter. If any abnormalities are observed, the solution should be discarded. Healthcare professionals are trained in the safe and effective administration of intravenous fluids and will utilize appropriate equipment and monitoring techniques to ensure patient safety and optimal therapeutic outcomes. Always consult a healthcare professional before using this medication.

Pros

Glucose-Solopharm Polyflac Domus offers several key advantages. Its isotonic nature minimizes the risk of fluid imbalances, a common concern with intravenous fluid administration. This is crucial for patient safety and reduces the likelihood of adverse reactions. The solution’s readily metabolizable dextrose provides a quick and efficient energy source for the body, particularly beneficial in situations requiring rapid energy replenishment. The convenient single-use vial packaging ensures sterility and ease of administration, reducing the risk of contamination.

The solution’s clear and colorless nature allows for easy visual inspection before administration, enabling the detection of any potential contamination or degradation. The inclusion of a small amount of sodium chloride contributes to maintaining electrolyte balance, which is essential for optimal cellular function. The rapid absorption and utilization of dextrose contributes to its effectiveness in addressing both fluid deficits and energy needs simultaneously. This combined effect makes it a valuable tool in various clinical settings where both hydration and energy support are necessary.

Furthermore, the well-established metabolic pathways of dextrose ensure a predictable and reliable therapeutic effect. The solution’s compatibility with standard intravenous administration equipment makes its use straightforward and convenient for healthcare professionals. The availability and affordability of this solution contribute to its widespread accessibility, making it a cost-effective option for various healthcare needs. The simplicity of its composition contributes to its safety profile, reducing the potential for complex drug interactions.

Cons

While Glucose-Solopharm Polyflac Domus offers numerous benefits, potential drawbacks should be considered. Although rare, some individuals may experience adverse reactions such as localized inflammation at the injection site, or more systemic reactions like fever or allergic responses. These reactions are usually mild and transient, but prompt medical attention is warranted if any significant adverse effects occur. Careful monitoring of the patient during and after infusion is vital to detect and manage any potential complications.

The solution, while providing essential glucose and fluids, is not a complete nutritional source. It lacks essential vitamins, minerals, and other nutrients necessary for optimal health. Therefore, it shouldn’t be considered a substitute for a balanced diet, particularly in patients requiring long-term nutritional support. Prolonged or excessive use might lead to imbalances in blood glucose levels, necessitating careful monitoring and adjustment of the infusion rate and dosage based on individual patient needs and response.

Furthermore, improper administration techniques can lead to complications such as phlebitis (inflammation of the vein) or extravasation (leakage of fluid into surrounding tissues). Strict adherence to sterile techniques and proper infusion rates is crucial to minimize these risks. Patients with pre-existing conditions, such as impaired kidney function or heart failure, may require special precautions and close monitoring during intravenous fluid administration. Any pre-existing conditions should always be communicated to the healthcare provider before initiating treatment with Glucose-Solopharm Polyflac Domus.

Important Considerations

Before administering Glucose-Solopharm Polyflac Domus, healthcare professionals should carefully assess the patient’s overall health status and any pre-existing conditions. Patients with a history of heart failure, kidney disease, or fluid retention may require special monitoring during and after infusion to prevent complications. Individuals with known allergies or sensitivities to dextrose or any of the solution’s components should be carefully evaluated to minimize the risk of allergic reactions. Close monitoring of vital signs, including blood pressure, heart rate, and respiratory rate, is recommended during the infusion process.

Regular monitoring of blood glucose levels is crucial, especially in patients with diabetes or impaired glucose metabolism. The infusion rate and total volume administered should be adjusted based on the patient’s response and blood glucose levels to prevent hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Patients should be observed for any signs of adverse reactions, such as inflammation at the injection site, fever, or allergic reactions. Prompt medical attention should be sought if any unusual symptoms develop during or after the infusion.

The solution should be visually inspected for any signs of particulate matter or discoloration before administration. Any abnormalities should prompt the immediate discarding of the solution. Glucose-Solopharm Polyflac Domus should be administered using sterile techniques to prevent infection. Proper handling and disposal of used equipment are also crucial to maintain patient safety. Healthcare professionals should be thoroughly familiar with the product’s package insert and follow all recommended guidelines for safe and effective administration. This collaborative approach, emphasizing careful monitoring and attention to detail, ensures optimal patient outcomes.

Conclusion

Glucose-Solopharm Polyflac Domus 5% infusion solution provides a valuable and readily available means of delivering essential glucose and fluids intravenously. Its straightforward composition, isotonic nature, and rapid metabolic utilization of dextrose make it a versatile tool in various clinical situations. The solution’s effectiveness in addressing both fluid deficits and energy needs simultaneously contributes to its widespread use in healthcare settings. However, the importance of careful patient assessment, meticulous administration techniques, and close monitoring of vital signs and blood glucose levels cannot be overstated.

While generally safe and well-tolerated, the potential for adverse reactions, though rare, necessitates vigilance on the part of healthcare professionals. The solution should be used judiciously, with careful consideration of individual patient needs and potential contraindications. It is crucial to remember that Glucose-Solopharm Polyflac Domus is not a complete nutritional substitute and should be used in conjunction with other appropriate therapies as part of a comprehensive treatment plan. The simplicity of this solution, coupled with its potential for rapid therapeutic benefit, highlights its value as a critical component of intravenous fluid management and energy support.

Ultimately, the successful and safe utilization of Glucose-Solopharm Polyflac Domus hinges on a collaborative approach between healthcare professionals and patients. This collaboration, characterized by careful assessment, precise administration, and rigorous monitoring, ensures that the benefits of this readily available solution are maximized while potential risks are minimized. Adherence to established guidelines and protocols for intravenous fluid administration remains paramount in optimizing patient outcomes and ensuring the responsible use of this important medical resource. The efficacy and safety of this solution are grounded in a thorough understanding of its properties and careful application within a broader clinical context.